NCT00147602CompletedPhase 4
A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Pfizer
- Enrollment
- 4,732
- Locations
- 129
- Primary Endpoint
- Time to occurrence of fatal or non-fatal stroke
Study Overview
Brief Summary
To determine whether Lipitor reduces stroke, compared to placebo in patients who have had a previous stroke or transient ischemic attack.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Previous stroke or TIA
Exclusion Criteria
- •coronary heart disease
Outcomes
Primary Outcomes
Time to occurrence of fatal or non-fatal stroke
Secondary Outcomes
- Time to occurrence of an acute coronary event, consisting of cardiac death, nonfatal myocardial infarction, resuscitated cardiac arrest or unstable angina.
- Time to occurrence of a cerebrovascular event, defined as fatal or nonfatal stroke or TIA.
Investigators
Study Sites (129)
Loading locations...
Similar Trials
Completed
Phase 3
A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)HypercholesterolemiaNCT00092651Organon and Co1,398
Completed
Phase 3
An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia (0653A-038)(COMPLETED)HypercholesterolemiaNCT00092664Organon and Co1,104
Completed
Phase 3
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)Coronary DiseaseHypercholesterolemiaNCT00092625Organon and Co442
Completed
Phase 3
Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)Coronary DiseaseHypercholesterolemiaNCT00092612Organon and Co372
Completed
Phase 3
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)Coronary DiseaseHypercholesterolemiaNCT00092638Organon and Co450